Erudio Healtherudio.com
Indication
Gastrointestinal stromal tumor (GIST)
1 HCP commentary report on clinical trials in Gastrointestinal stromal tumor (GIST). Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| StrateGIST 3 NCT07218926 · GlaxoSmithKline | metastatic and/or unresectable gastrointestinal stromal tumors after imatinib | Phase 3 | 84 | 17 | Focused | Oct 31, 2026 | Preview |